| PERIOD ENDING | 31-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 34,489 | 30,645 | 29,903 | 35,081 | | Cost of Revenue | 13,391 | 11,710 | 11,220 | 13,384 | | | Gross Profit | 21,098 | 18,935 | 18,683 | 21,697 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,900 | 18,179 | 20,254 | 20,610 | | Non Recurring | 5,616 |
-
|
-
|
-
| | Others | 2,690 | 1,990 | 1,808 | 1,805 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,108) | (1,234) | (3,379) | (718) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (67) | 20 | 21 | 53 | | Earnings Before Interest And Taxes | (6,175) | (1,438) | (3,134) | (665) | | Interest Expense | 716 | 740 | 765 | 828 | | Income Before Tax | (6,891) | (2,178) | (3,899) | (1,493) | | Income Tax Expense | (2,314) | 2,875 | (3,266) | (924) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,577) | (5,053) | (633) | (569) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,577) | (5,053) | (633) | (569) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,577) | ($5,053) | ($633) | ($569) |
|
0.31% Nasdaq 0.00%
Income Statement
